CFI Vancouver is proud to present a talk on the Science of Harm Reduction Drug Policy by Dr. Thomas Kerr.
Dr. Thomas Kerr is Co-Director of the Urban Health Research Initiative at the British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), and an Associate Professor in the Department of Medicine, Division of AIDS at the University of British Columbia.
Dr. Kerr is a principal investigator of several large cohort studies involving people who inject drugs and individuals living with HIV/AIDS. Dr. Kerr’s primary research interests are HIV/AIDS, injection drug use, health policy and service evaluation, and community-based research methods. A key focus of Dr. Kerr’s work has been the scientific evaluation of Insite, North America’s first safer injecting facility. Dr. Kerr has published over 300 scientific papers in international peer-reviewed journals and most recently Dr. Kerr was the co-recipient of the Alfred R. Lindesmith Award for Achievement in the Field of Scholarship, which recognizes scholars whose personal courage and quality of published research constitute a source of inspiration in drug policy scholarship.
Harm reduction drug policy has become a politically polarizing issue, which often leaves the science behind the rhetoric. With recent court challenges over Vancouver's safe injection site, Insite; society must become scientifically informed on what strategies are effective in treating addiction and improving public health.
This talk will take place in room A102 of Buchanan building block A at UBC. There is a suggested donation of $5 to $10.